NDC 80425-0279-01 - Amoxicillin and Clavulanate Potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0279
- Requested NDC
- 80425-0279-01
- Package NDCs from labels
- 80425-0279-1, 80425-0279-2, 80425-0279-3, 80425-0279-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2025-02-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amoxicillin and Clavulanate Potassium - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2025-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0279-1 | Amoxicillin and Clavulanate Potassium | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | 3 | |
| 80425-0279-2 | Amoxicillin and Clavulanate Potassium | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 3 | |
| 80425-0279-3 | Amoxicillin and Clavulanate Potassium | 14 in 1 BOTTLE | TABLET, FILM COATED | 14 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0279 | AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 3 | Current NDC, 3 package rows | 20250204_f601c634-2271-2fcd-e053-2995a90aaaba.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0279-1 | EA - Each | 80425-0279 | deca8df9-5797-4f1c-b6e7-df35b467be0d | 1 | 2023-04-07 |
| 80425-0279-2 | EA - Each | 80425-0279 | f9079f26-45d5-453d-848e-27c87efc1afb | 1 | 2023-04-07 |
| 80425-0279-3 | EA - Each | 80425-0279 | 0832f42e-e1b2-4437-b7f9-e67bdd962b6d | 1 | 2025-03-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMOXICILLIN | AMOXICILLIN | REMEDYREPACK INC. | 4adc198e-39d8-4b3e-bfa4-278aaf4064ae | 2026-09-09 | Warnings, Adverse reactions | 804826J2HU |
| AMOXICILLIN | AMOXICILLIN | Chartwell RX, LLC | b07b5ac4-253e-4c83-91c3-3fdc46e91a0f | 2026-09-04 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | REMEDYREPACK INC. | b6ea2f81-aee6-4c88-b681-50eb28e80a86 | 2026-09-03 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Redpharm Drug | 5a79669f-52f7-e8ea-e063-6394a90a93b8 | 2026-09-02 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | REMEDYREPACK INC. | f37eb415-77b2-41b0-8d20-64e821e4b05d | 2026-09-02 | Warnings, Adverse reactions | 804826J2HU |
| AMOXICILLIN | AMOXICILLIN | Redpharm Drug | 5a660370-9a81-33f9-e063-6394a90a6c62 | 2026-09-01 | Warnings, Adverse reactions | 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | REMEDYREPACK INC. | a26f2ceb-bb9b-4813-9691-634338186860 | 2026-08-31 | Warnings, Adverse reactions | 562508 Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Sportpharm LLC | 69e45bc0-de57-4603-a9eb-335988dfe0bf | 2026-08-29 | Warnings, Adverse reactions | ANDA091568 562508 Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | Sportpharm LLC | c4d4aeca-f63c-4548-a9b7-7f627e8fd45c | 2026-08-29 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | REMEDYREPACK INC. | e5b0770d-1301-498e-a4ed-41874d7bf225 | 2026-08-27 | Warnings, Adverse reactions | 562508 Q42OMW3AT8 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | 7526a33a-18d6-36ca-e053-2a91aa0ab9f9 | 2026-08-26 | Warnings, Adverse reactions | 562508 Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 4937611d-bd61-4538-ad1e-bd67e9527955 | 2026-08-25 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 1bda03a2-6c7d-4c9e-b98a-e5e01bebb3b1 | 2026-08-24 | Warnings, Adverse reactions | ANDA091568 562508 Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | REMEDYREPACK INC. | 82c0c5d1-df2d-4352-bd12-99f955af569e | 2026-08-20 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | REMEDYREPACK INC. | 3a4afd36-dffa-44a1-9d09-e93cf66053bf | 2026-08-20 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | REMEDYREPACK INC. | c88b2b50-c664-43b3-9c37-f134a329dc21 | 2026-08-14 | Warnings, Adverse reactions | 562508 Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | REMEDYREPACK INC. | 80bef3fd-4f6f-4190-8865-9ac46c8947a3 | 2026-08-14 | Warnings, Adverse reactions | ANDA091568 562508 Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | a1d6bf78-4bb7-469e-ba39-318e14aaee29 | 2026-08-13 | Warnings, Adverse reactions | ANDA091568 562508 Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Aurobindo Pharma Limited | 3ae0c95f-7ffa-4317-9fea-4d07b86bee72 | 2026-08-13 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | fbd40fcd-bf5b-e91e-e053-6394a90a609c | 2026-08-12 | Warnings, Adverse reactions | 562508 Q42OMW3AT8 804826J2HU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.